Walkers advised Genetron Holdings Limited on US$256 IPO on Nasdaq

Walkers has advised Beijing-based Genetron Holdings Limited on the Cayman and BVI aspects of its US$256m IPO on Nasdaq. Genetron is a leading precision oncology company specializing in cancer molecular profiling with products and services covering full-cycle of cancer care.

Hong Kong partner Jo Lit led the Walkers team and was supported by Senior Associate Tiffy Wan and Legal Manager Kevin Ho. Davis Polk & Wardwell LLP advised Genetron on the international law aspects while Shihui Partners advised Genetron on the PRC law aspects. Clifford Chance and Fangda Partners advised the underwriters on this listing.

Jo LitPartnerT +852 2596 3383jo.lit@walkersglobal.com
Tiffy WanSenior AssociateT +852 2596 3379tiffy.wan@walkersglobal.com
Kevin HoLegal ManagerT +852 2596 3455kevin.ho@walkersglobal.com